Fig 1: Immunohistochemical staining of target proteins in human hepatic cellular carcinoma and normal liver tissue.(A-E) Representative immunohistochemical images showing the expression of FDPS, FKBP1A, HB-EGF, KLRB1 (CD161), and NDRG1 in HCC tissue specimens. (F–J) Corresponding images of target protein expression in normal liver tissue. Positive staining was consistently observed in HCC samples, with notable localization to sinusoidal endothelial cells, whereas expression in normal liver tissue was largely negative or weakly positive.
Fig 2: Establishment of multi-gene prediction signature in TCGA cohort.(A) A Venn diagram illustrated 249 DEGs and 27 genes with prognostic value, resulting in 24 ECs-related genes. (B) Forest plot showing five genes (NDRG1, HBEGF, FKBP1A, KLRB1, and FDPS) selected via Lasso-Cox and multivariable Cox regression analyses. (C) Risk stratification of patients with HCC into high- and low-risk groups based on the median risk score. (D–F) PCA and t-SNE analyses illustrating the distinct distribution of patients across the two risk groups, with shorter survival durations observed in the high-risk group. (G) Kaplan–Meier survival curves demonstrating significantly reduced overall survival in the high-risk group. (H) Time-dependent ROC curves evaluating the predictive performance of the model for 1-, 3-, and 5-year survival outcomes.
Supplier Page from Abcam for Anti-FDPS/FPS antibody [EPR4628]